Aurinia Pharmaceuticals
Price & Volume
Stats
See more52W Range | $6.55-$13.54 |
Market Cap | $1.5B |
Shares Short | 9M |
Financials
See moreRevenue (12 Mos) | $260.1M |
Revenue Growth (YoY) | 22.4% |
Gross Profit (12 Mos) | $208.5M |
Diluted EPS | $0.43 |
News
See moreYahoo Finance • 12 days ago
Sector Update: Health Care Stocks Climb Late Afternoon
Yahoo Finance • 12 days ago
Aurinia responds after top FDA official’s comment on lead drug
Yahoo Finance • 13 days ago
Aurinia Pharma Reaffirms LUPKYNIS Safety And Efficacy Following Retracted FDA Official's Post
Yahoo Finance • 28 days ago
7 Biotech Stocks Trading At 52-Week Highs - Can The Rally Continue?
About
CEO | Mr. Peter S. Greenleaf M.B.A. |
Address | #140, 14315 ? 118 Avenue, Edmonton, AB, Canada, T5L 4S6 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 130 |
